Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Atlanta Braves Holdings, Inc.BATRK · Entity 4131 | See remarks | December 11, 2025 | December 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Atlanta Braves Holdings, Inc.
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series C Common StockSEC Table I · non-derivative | Direct | 6,040 |
Ending reported balance
After 2025-12-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-12-11 · Exercise / conversion · Acquired 1,880 · Balance 6,866 F1: Each restricted stock unit converted into one share of Series C Common Stock. Row 2 · 2025-12-12 · Sale · Disposed 826 · Balance 6,040 F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F3: Reflects the weighted average sale price. The range of prices for such transaction is $39.41 to $40.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| Restricted Stock Units - BATRKSEC Table II · derivative / convertible security | Direct | 1,881 |
Reported balance
After 2025-12-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-12-11 · Exercise / conversion · Disposed 1,880 · Balance 1,881 F4: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. F5: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit converted into one share of Series C Common Stock.
F2: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
F3: Reflects the weighted average sale price. The range of prices for such transaction is $39.41 to $40.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F4: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
F5: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2025 Filed Dec 15, 2025 16:01 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 826 | $39.71 | $32,800.46 |
DisclosureSEC source: 0001104659-25-121102 · tm2533513-1_4seq1.xml · nonDerivative · entry 2 Rhodes DeRetta C. · CIK 0002035944 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,040 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F3 · price: Reflects the weighted average sale price. The range of prices for such transaction is $39.41 to $40.04. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 16:01 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 1,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-121102 · tm2533513-1_4seq1.xml · derivative · entry 3 Rhodes DeRetta C. · CIK 0002035944 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,881 Underlying: Series C Common Stock · 1,880 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. F5 · derivative.exercise_date: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026. F5 · derivative.expiration_date: One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 16:01 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 1,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-121102 · tm2533513-1_4seq1.xml · nonDerivative · entry 1 Rhodes DeRetta C. · CIK 0002035944 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 16:06 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 1,501 | $38.70 | $58,088.70 |
DisclosureSEC source: 0001104659-25-119292 · tm2532980-7_4seq1.xml · nonDerivative · entry 2 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,986 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F3 · price: Reflects the weighted average sale price. The range of prices for such transaction is $38.57 to $38.79. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 16:06 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | GrantRestricted Stock Units - BATRK · Derivative | 3,499 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-119292 · tm2532980-7_4seq1.xml · derivative · entry 4 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,499 Underlying: Series C Common Stock · 3,499 shares Expires 2026-12-04 F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 16:06 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-119292 · tm2532980-7_4seq1.xml · derivative · entry 3 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series C Common Stock · 3,375 shares Expires 2025-12-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 16:06 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-119292 · tm2532980-7_4seq1.xml · nonDerivative · entry 1 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. Read SEC document |
| May 15, 2025 Filed May 15, 2025 19:16 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionStock option (Right to Buy) - BATRK · Derivative | 5,000 | $0.00 Strike: $27.18 | $0.00 |
DisclosureSEC source: 0001104659-25-049667 · tm2515309-1_4seq1.xml · derivative · entry 4 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,855 Underlying: Series C Common Stock · 5,000 shares Expires 2027-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option award is fully-vested. Read SEC document |
| May 15, 2025 Filed May 15, 2025 19:16 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 5,000 | $41.20 | $206,000.00 |
DisclosureSEC source: 0001104659-25-049667 · tm2515309-1_4seq1.xml · nonDerivative · entry 3 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,112 Read SEC document |
| May 15, 2025 Filed May 15, 2025 19:16 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 5,000 | $27.18 | $135,900.00 |
DisclosureSEC source: 0001104659-25-049667 · tm2515309-1_4seq1.xml · nonDerivative · entry 2 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2025 Filed May 15, 2025 19:16 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 767 | $40.97 | $31,423.99 |
DisclosureSEC source: 0001104659-25-049667 · tm2515309-1_4seq1.xml · nonDerivative · entry 1 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,112 Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 16:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | SaleSeries C Common Stock | 2,528 | $39.93 | $100,943.04 |
DisclosureSEC source: 0001104659-24-128474 · tm2431058-6_4seq1.xml · nonDerivative · entry 3 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,879 F2 · kind: The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. F3 · price: Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $39.76 to $40.26. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 16:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 1,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128474 · tm2431058-6_4seq1.xml · derivative · entry 5 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,761 Underlying: Series C Common Stock · 1,880 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. F5 · derivative.exercise_date: One-third of the restricted stock unit award vested on December 11, 2024, and the remaining restricted stock units vest in substantially equal installments on each of December 11, 2025 and 2026. F5 · derivative.expiration_date: One-third of the restricted stock unit award vested on December 11, 2024, and the remaining restricted stock units vest in substantially equal installments on each of December 11, 2025 and 2026. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 16:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionRestricted Stock Units - BATRK · Derivative | 3,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128474 · tm2431058-6_4seq1.xml · derivative · entry 4 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series C Common Stock · 3,760 shares Expires 2024-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 16:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 1,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128474 · tm2431058-6_4seq1.xml · nonDerivative · entry 2 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 16:40 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | Exercise / conversionSeries C Common Stock | 3,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-128474 · tm2431058-6_4seq1.xml · nonDerivative · entry 1 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converted into one share of Series C Common Stock. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 16:56 UTC | Atlanta Braves Holdings, Inc. BATRK · Entity 4131 | GrantRestricted Stock Units - BATRK · Derivative | 3,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-126341 · tm2430393-3_4seq1.xml · derivative · entry 1 Rhodes DeRetta C. · CIK 0002035944 · EVP, Chief Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,375 Underlying: Series C Common Stock · 3,375 shares Expires 2025-12-04 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.